<code id='310D7CB5A8'></code><style id='310D7CB5A8'></style>
    • <acronym id='310D7CB5A8'></acronym>
      <center id='310D7CB5A8'><center id='310D7CB5A8'><tfoot id='310D7CB5A8'></tfoot></center><abbr id='310D7CB5A8'><dir id='310D7CB5A8'><tfoot id='310D7CB5A8'></tfoot><noframes id='310D7CB5A8'>

    • <optgroup id='310D7CB5A8'><strike id='310D7CB5A8'><sup id='310D7CB5A8'></sup></strike><code id='310D7CB5A8'></code></optgroup>
        1. <b id='310D7CB5A8'><label id='310D7CB5A8'><select id='310D7CB5A8'><dt id='310D7CB5A8'><span id='310D7CB5A8'></span></dt></select></label></b><u id='310D7CB5A8'></u>
          <i id='310D7CB5A8'><strike id='310D7CB5A8'><tt id='310D7CB5A8'><pre id='310D7CB5A8'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:4145
          Johnson & Johnson sign
          MARK RALSTON/AFP via Getty Images

          WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

          J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

          advertisement

          The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more
          In key trial, Verve's treatment lowers cholesterol levels in patients
          In key trial, Verve's treatment lowers cholesterol levels in patients

          APStockVerveTherapeuticssaidSundaythatthefirst10peopletoreceiveaone-timetreatmentpoweredbyaformofCRI

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Delta passengers in Vegas fall sick while waiting on flight in triple

          1:30InthisMarch4,2018,filephoto,aBoeing737jetliner,belongingtoDeltaAirlines,isshownonthetarmacMcCarr